[1]董淳强 杨体泉 董 昆.缺氧诱导因子-1α在小儿肾母细胞瘤中的表达[J].临床小儿外科杂志,2013,12(02):85-89.[doi:10.3969/j.issn.1671— 6353.2013.02.003]
 DONG Chun-qiang,YANG Ti-quan,DONG Kun.Expression of hypoxia inducible factor-1 alpha in pediatric nephroblastoma[J].Journal of Clinical Pediatric Surgery,2013,12(02):85-89.[doi:10.3969/j.issn.1671— 6353.2013.02.003]
点击复制

缺氧诱导因子-1α在小儿肾母细胞瘤中的表达

参考文献/References:

1 Pritchard-Jones K, Moroz V, Vujanic G, et al. Treatment and outcome of Wilms’ tumour patients: an analysis of all cases registered in the UKW 3trial[J]. Ann Oncol, 2012,23(9):245 7— 63. 2Vaupel P. Tumor microenvironmental physiology and its implications for radiation oncology[J]. Semin Radiat Oncol, 2004,14(3):19 8— 206. 3Shen G, Li X, Jia Y, et al. Hypoxia-regulated microRNAs in human cancer.LID-10.1038/aps.2012.19 5[doi][J]. Acta Pharmacol Sin, 2013. 4Nakamura L, Ritchey M. Current management of wilms’ tumor[J]. Curr Urol Rep, 2010,11(1):5 8— 65. 5Weidner N. Intratumor microvessel density as a prognostic factor in cancer[J]. Am J Pathol, 1995,147(1): 9— 19. 6Majmundar AJ, Wong WJ, Simon MC. Hypoxia-inducible factors and the response to hypoxic stress[J]. Mol Cell, 2010,40(2):29 4— 309. 7Semenza GL.Regulation of oxygen homeostasis by hypoxia-inducible factor 1[J]. Physiology(Bethesda),2009,24:9 7— 106. 8Liu W, Shen SM, Zhao XY, et al. Targeted genes and interacting proteins of hypoxia inducible factor-1[J]. Int J Biochem Mol Biol, 2012,3(2):16 5— 178. 9Semenza GL. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics[J]. Oncogene, 2010,29(5):62 5— 634. 10Isobe T,Aoyagi K,Koufuji K,et al.Clinicopathological significance of hypoxia-inducible factor-1 alpha(HIF-1alpha)expression in gastric cancer[J].Int J Clin Oncol,2012. 11Preusser M, Hassler M, Birner P, et al. Microvascularization and expression of VEGF and its receptors in recurring meningiomas: pathobiological data in favor of anti-angiogenic therapy approaches[J].Clin Neuropathol, 2012,31(5):35 2— 60. 1 2Sakurai T, Kudo M. Signaling pathways governing tumor angiogenesis[J]. Oncology, 2011,81(1):2 4— 29. 1 3Rezvani HR, Ali N, Nissen LJ, et al. HIF-1alpha in epidermis: oxygen sensing, cutaneous angiogenesis, cancer, and non-cancer disorders[J]. J Invest Dermatol, 2011,131(9):179 3— 805. 1 4Patel-Hett S, D’Amore PA. Signal transduction in vasculogenesis and developmental angiogenesis[J]. Int J Dev Biol, 2011,55(4-5):35 3— 63. 1 5Schito L,Rey S,Tafani M,et al.Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells[J].Proc Natl Acad Sci U S A,2012,109(40):E270 7— 2716. 1 6Ryan HE, Poloni M, McNulty W, et al. Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth[J]. Cancer Res, 2000,60(15):40 10— 4015. 1 7Harada H, Inoue M, Itasaka S, et al. Cancer cells that survive radiation therapy acquire HIF-1 activity and translocate towards tumour blood vessels[J]. Nat Commun, 2012,3:783. 1 8Nurwidya F, Takahashi F, Minakata K, et al. From tumor hypoxia to cancer progression: the implications of hypoxia-inducible factor-1 expression in cancers[J]. Anat Cell Biol, 2012,45(2):7 3— 78. 1 9Isobe T,Aoyagi K,Koufuji K,et al.Clinicopathological significance of hypoxia-inducible factor-1 alpha(HIF-1alpha)expression in gastric cancer[J].Int J Clin Oncol,2012. 20 Charpin C, Tavassoli F, Secq V, et al. Validation of an immunohistochemical signature predictive of 8-year outcome for patients with breast carcinoma[J]. Int J Cancer, 2012,131(3):E23 6— 243. 21 Nepal M, Choi HJ, Choi BY, et al. Anti-angiogenic and anti-tumor activity of Bavachinin by targeting hypoxia-inducible factor-1alpha[J]. Eur J Pharmacol, 2012,691(1-3):2 8— 37. 2 2Naik R, Won M, Kim BK, et al. Synthesis and structure-activity relationship of(E)-phenoxyacrylic amide derivatives as hypoxia-inducible factor(HIF)1alpha inhibitors[J]. J Med Chem, 2012,55(23):1056 4— 10571.

相似文献/References:

[1]李民驹. Ⅲ、Ⅳ期肾母细胞瘤综合治疗15年经验[J].临床小儿外科杂志,2011,10(04):243.
 [J].Journal of Clinical Pediatric Surgery,2011,10(02):243.
[2]张广超 钱蔷英 阮双岁. 69例小儿Wilms瘤的超声检查分析[J].临床小儿外科杂志,2012,11(02):134.
[3]顾涛,井颖,王建林,等.KAI1/CD82表达水平与肾母细胞瘤转移的相关性研究[J].临床小儿外科杂志,2016,15(05):491.
[4]蒋鸿飞,林涛,石秦林.肾母细胞瘤综合治疗研究进展[J].临床小儿外科杂志,2020,19(10):916.[doi:10.3969/j.issn.1671-6353.2020.10.010]
 Jiang Hongfei,Lin Tao,Shi Qinlin.Research advances in the treatments of Wilms’ tumor[J].Journal of Clinical Pediatric Surgery,2020,19(02):916.[doi:10.3969/j.issn.1671-6353.2020.10.010]
[5]刘沛,杨洋,黄蕾,等.肾母细胞瘤常规行淋巴结清扫术对预后的影响研究[J].临床小儿外科杂志,2022,21(12):1111.[doi:10.3760/cma.j.cn101785-202205079-003]
 Liu Pei,Yang Yang,Huang Lei,et al.Outcomes of event-free survival in children with Wilms tumor undergoing routine lymph node dissection[J].Journal of Clinical Pediatric Surgery,2022,21(02):1111.[doi:10.3760/cma.j.cn101785-202205079-003]
[6]屈彦超,张潍平,孙宁,等.儿童双侧肾母细胞瘤手术后复发的再治疗[J].临床小儿外科杂志,2022,21(12):1123.[doi:10.3760/cma.j.cn101785-202107017-005]
 Qu Yanchao,Zhang Weiping,Sun Ning,et al.Treatment of recurrent bilateral Wilms tumor in children: a report of 10 cases[J].Journal of Clinical Pediatric Surgery,2022,21(02):1123.[doi:10.3760/cma.j.cn101785-202107017-005]
[7]刘珊,常晓峰,任清华,等.儿童肾外肾母细胞瘤3例及文献回顾[J].临床小儿外科杂志,2024,(03):279.[doi:10.3760/cma.j.cn101785-202204016-015]
 Liu Shan,Chang Xiaofeng,Ren Qinghua,et al.Pediatric extrarenal Wilm’s tumor: a report of 3 cases with a literature review[J].Journal of Clinical Pediatric Surgery,2024,(02):279.[doi:10.3760/cma.j.cn101785-202204016-015]
[8]姚伟,宋治莹,杨家健,等.单侧肾母细胞瘤新辅助化疗后保留肾单位手术的初步疗效分析[J].临床小儿外科杂志,2024,(04):372.[doi:10.3760/cma.j.cn101785-202403060-013]
 Yao Wei,Song Zhiyin,Yang Jiajian,et al.Preliminary analysis of nephron sparing surgery for unilateral Wilms tumor after neoadjuvant chemotherapy[J].Journal of Clinical Pediatric Surgery,2024,(02):372.[doi:10.3760/cma.j.cn101785-202403060-013]

更新日期/Last Update: 2013-04-30